色素脱失症治療の世界市場

◆英語タイトル:Hypopigmentation Disorder Treatment Market (Treatment - Topical Drugs, Laser Therapy, Chemical Peels, Microdermabrasion, Others (phototherapy, etc.); Disease Indication: Vitiligo, Albinism; End user - Hospitals, Aesthetic Clinics and Dermatology Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
◆商品コード:TPM-C03066
◆発行会社(リサーチ会社):Transparency Market Research
◆発行日:2019年2月
◆ページ数:178
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,795 ⇒換算¥637,450見積依頼/購入/質問フォーム
Multi UserUSD8,795 ⇒換算¥967,450見積依頼/購入/質問フォーム
Global Site LicenseUSD11,795 ⇒換算¥1,297,450見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTransparency Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Transparency Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Transparency Market Researchが調査・発行した当レポートは、色素脱失症治療の世界市場について調べ、色素脱失症治療の世界規模、市場動向、市場環境、治療別(局所薬、レーザー療法、ケミカルピール、マイクロダーマブレーション、その他)分析、適応症別(白斑、白化症)分析、エンドユーザー別(病院、美容クリニック・皮膚科センター)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめました。
・序文・調査範囲・調査手法
・エグゼクティブサマリー
・色素脱失症治療の世界市場動向
・色素脱失症治療の世界市場環境
・色素脱失症治療の世界市場規模
・色素脱失症治療の世界市場規模:治療別(局所薬、レーザー療法、ケミカルピール、マイクロダーマブレーション、その他)
・色素脱失症治療の世界市場規模:適応症別(白斑、白化症)
・色素脱失症治療の世界市場規模:エンドユーザー別(病院、美容クリニック・皮膚科センター)
・色素脱失症治療の世界市場:地域別市場規模・分析
・色素脱失症治療の北米市場規模・予測
・色素脱失症治療のアメリカ市場規模・予測
・色素脱失症治療の中南米市場規模・予測
・色素脱失症治療のヨーロッパ市場規模・予測
・色素脱失症治療のアジア市場規模・予測
・色素脱失症治療の日本市場規模・予測
・色素脱失症治療の中国市場規模・予測
・色素脱失症治療のインド市場規模・予測
・色素脱失症治療の中東市場規模・予測
・色素脱失症治療のアフリカ市場規模・予測
・競争状況・関連企業情報
【レポートの概要】

Global Hypopigmentation Disorder Treatment Market: Overview

This report analyzes the current and future scenario of the global hypopigmentation disorder treatment market. Increase in patient population with hypopigmentation disorders, growth of the pharmaceutical industry, improvement in health care infrastructure, and increase in the number of clinical trials are projected to be the major drivers of the global market during the forecast period.

The global hypopigmentation disorder treatment market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on treatment, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market, and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global hypopigmentation disorder treatment market.

Global Hypopigmentation Disorder Treatment Market: Key Segments

Based on treatment, the global hypopigmentation disorder treatment market has been segmented into topical drugs, laser therapy, chemical peels, microdermabrasion, and others (phototherapy, etc.). The segments have been analyzed based on available drug products used in the treatment of hypopigmentation disorders, cost-effectiveness, and preference for industries. In terms of diseases indication, the market has been classified into vitiligo, albinism, and others. Based on end-user, the global hypopigmentation disorder treatment market has been classified into hospitals, aesthetic clinics & dermatology centers, and others. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Hypopigmentation Disorder Treatment Market: Regional Outlook

In terms of region, the global hypopigmentation disorder treatment market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global hypopigmentation disorder treatment market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players profiled in the market report include Allergan, SkinCeuticals, Pierre Fabre, Episciences, Inc., RXi Pharmaceuticals Corporation, Obagi Cosmeceuticals LLC (Obagi Medical), and Alvogen.

The global hypopigmentation disorder treatment market has been segmented as below:

Global Hypopigmentation Disorder Treatment Market, by Treatment
Topical Drugs
Laser
Chemical Peels
Microdermabrasion
Others (phototherapy, etc.)
Global Hypopigmentation Disorder Treatment Market, by Disease Indication
Vitiligo
Albinism
Others
Global Hypopigmentation Disorder Treatment Market, by End-user
Hospitals
Aesthetic Clinics & Dermatology Centers
Others
Global Hypopigmentation Disorder Treatment Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
Italy
France
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of Middle East & Africa

【レポートの目次】

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights

2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology

3. Executive Summary

4. Market Overview
4.1. Market Overview
4.2. Global Hypopigmentation Disorders Treatment Market Analysis
4.3. Global Hypopigmentation Disorders Treatment Market Overview
4.4. Porter’s Five Forces Analysis
4.5. Pipeline Analysis
4.6. Key Partnership & Acquisitions
4.7. Disease Prevalence and Incidence: Global Overview
4.8. Regulatory Scenario

5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Key Trends

6. Global Hypopigmentation Disorders Treatment Market Analysis, by Treatment
6.1. Introduction
6.2. Global Hypopigmentation Disorders Treatment Market Value Share Analysis, by Treatment
6.3. Global Hypopigmentation Disorders Treatment Market Forecast, by Treatment
6.4. Global Hypopigmentation Disorders Treatment Market Analysis, by Treatment
6.4.1. Topical Drugs
6.4.2. Laser Therapy
6.4.3. Chemical Peels
6.4.4. Microdermabrasion
6.4.5. Others (phototherapy, etc.)
6.5. Global Hypopigmentation Disorders Treatment Market Attractiveness Analysis, by Treatment

7. Global Hypopigmentation Disorders Treatment Market Analysis, by Disease Indication
7.1. Introduction
7.2. Global Hypopigmentation Disorders Treatment Market Value Share Analysis, by Disease Indication
7.3. Global Hypopigmentation Disorders Treatment Market Forecast, by Disease Indication
7.4. Global Hypopigmentation Disorders Treatment Market Analysis, by Disease Indication
7.4.1. Vitiligo
7.4.2. Albinism
7.4.3. Others
7.5. Global Hypopigmentation Disorders Treatment Market Attractiveness Analysis

8. Global Hypopigmentation Disorders Treatment Market Analysis, by End-user
8.1. Introduction
8.2. Global Hypopigmentation Disorders Treatment Market Value Share Analysis, by End-user
8.3. Global Hypopigmentation Disorders Treatment Market Forecast, by End-user
8.4. Global Hypopigmentation Disorders Treatment Market Analysis, by End-user
8.4.1. Hospitals
8.4.2. Aesthetic Clinics & Dermatology Centers
8.4.3. Others
8.5. Global Hypopigmentation Disorders Treatment Market Attractiveness Analysis, by End-user

9. Global Hypopigmentation Disorders Treatment Market Analysis, by Region
9.1. Global Market Scenario
9.2. Global Hypopigmentation Disorders Treatment Market Value Share Analysis, by Region
9.3. Global Hypopigmentation Disorders Treatment Market Forecast, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4. Global Hypopigmentation Disorders Treatment Market Attractiveness Analysis, by Region

10. North America Hypopigmentation Disorders Treatment Market Analysis
10.1. North America Hypopigmentation Disorders Treatment Market Analysis
10.2. North America Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Country
10.3. North America Hypopigmentation Disorders Treatment Market Forecast, by Country
10.3.1. U.S.
10.3.2. Canada
10.4. North America Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Treatment
10.5. North America Hypopigmentation Disorders Treatment Market Forecast, by Treatment
10.5.1. Topical Drugs
10.5.2. Laser Therapy
10.5.3. Chemical Peels
10.5.4. Microdermabrasion
10.5.5. Others (phototherapy, etc.)
10.6. North America Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Disease Indication
10.7. North America Hypopigmentation Disorders Treatment Market Forecast, by Disease Indication
10.7.1. Vitiligo
10.7.2. Albinism
10.7.3. Others
10.8. North America Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by End-user
10.8.1. Hospitals
10.8.2. Aesthetic Clinics & Dermatology Centers
10.8.3. Others

11. Europe Hypopigmentation Disorders Treatment Market Analysis
11.1. Europe Hypopigmentation Disorders Treatment Market Analysis
11.2. Europe Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
11.3. Europe Hypopigmentation Disorders Treatment Market Forecast, by Country/Sub-region
11.3.1. Germany
11.3.2. France
11.3.3. U.K.
11.3.4. Italy
11.3.5. Spain
11.3.6. Rest of Europe
11.4. Europe Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Treatment
11.5. Europe Hypopigmentation Disorders Treatment Market Forecast, by Treatment
11.5.1. Topical Drugs
11.5.2. Laser Therapy
11.5.3. Chemical Peels
11.5.4. Microdermabrasion
11.5.5. Others (phototherapy, etc.)
11.6. Europe Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Disease Indication
11.7. Europe Hypopigmentation Disorders Treatment Market Forecast, by Disease Indication
11.7.1. Vitiligo
11.7.2. Albinism
11.7.3. Others
11.8. Europe Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by End-user
11.8.1. Hospitals
11.8.2. Aesthetic Clinics & Dermatology Centers
11.8.3. Others

12. Asia Pacific Hypopigmentation Disorders Treatment Market Analysis
12.1. Asia Pacific Hypopigmentation Disorders Treatment Market Analysis
12.2. Asia Pacific Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.3. Asia Pacific Hypopigmentation Disorders Treatment Market Forecast, by Country/Sub-region
12.3.1. China
12.3.2. Japan
12.3.3. India
12.3.4. Australia & New Zealand
12.3.5. Rest of Asia Pacific
12.4. Asia Pacific Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Treatment
12.5. Asia Pacific Hypopigmentation Disorders Treatment Market Forecast, by Treatment
12.5.1. Topical Drugs
12.5.2. Laser Therapy
12.5.3. Chemical Peels
12.5.4. Microdermabrasion
12.5.5. Others (phototherapy, etc.)
12.6. Asia Pacific Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Disease Indication
12.7. Asia Pacific Hypopigmentation Disorders Treatment Market Forecast, by Disease Indication
12.7.1. Vitiligo
12.7.2. Albinism
12.7.3. Others
12.8. Asia Pacific Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by End-user
12.8.1. Hospitals
12.8.2. Aesthetic Clinics & Dermatology Centers
12.8.3. Others

13. Latin America Hypopigmentation Disorders Treatment Market Analysis
13.1. Latin America Hypopigmentation Disorders Treatment Market Analysis
13.2. Latin America Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3. Latin America Hypopigmentation Disorders Treatment Market Forecast, by Country/Sub-region
13.3.1. Brazil
13.3.2. Mexico
13.3.3. Rest of Latin America
13.4. Latin America Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Treatment
13.5. Latin America Hypopigmentation Disorders Treatment Market Forecast, by Treatment
13.5.1. Topical Drugs
13.5.2. Laser Therapy
13.5.3. Chemical Peels
13.5.4. Microdermabrasion
13.5.5. Others (phototherapy, etc.)
13.6. Latin America Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Disease Indication
13.7. Latin America Hypopigmentation Disorders Treatment Market Forecast, by Disease Indication
13.7.1. Vitiligo
13.7.2. Albinism
13.7.3. Others
13.8. Latin America Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by End-user
13.8.1. Hospitals
13.8.2. Aesthetic Clinics & Dermatology Centers
13.8.3. Others

14. Middle East & Africa Hypopigmentation Disorders Treatment Market Analysis
14.1. Middle East & Africa Hypopigmentation Disorders Treatment Market Analysis
14.2. Middle East & Africa Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
14.3. Middle East & Africa Hypopigmentation Disorders Treatment Market Forecast, by Country/Sub-region
14.3.1. GCC Countries
14.3.2. South Africa
14.3.3. Rest of MEA
14.4. Middle East & Africa Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Treatment
14.5. Middle East & Africa Hypopigmentation Disorders Treatment Market Forecast, by Treatment
14.5.1. Topical Drugs
14.5.2. Laser Therapy
14.5.3. Chemical Peels
14.5.4. Microdermabrasion
14.5.5. Others (phototherapy, etc.)
14.6. Middle East & Africa Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Disease Indication
14.7. Middle East & Africa Hypopigmentation Disorders Treatment Market Forecast, by Disease Indication
14.7.1. Vitiligo
14.7.2. Albinism
14.7.3. Others
14.8. Middle East & Africa Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by End-user
14.8.1. Hospitals
14.8.2. Aesthetic Clinics & Dermatology Centers
14.8.3. Others

15. Competition Landscape
15.1. Hypopigmentation Disorders Treatment Market Share Analysis, by Company
15.2. Competition Matrix
15.3. Company Profile
15.3.1. Allergan
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. SkinCeuticals
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Pierre Fabre
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Episciences, Inc.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Rxi Pharmaceutical Corporation
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Obagi Cosmeceuticals LLC (Obagi Medical)
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Alvogen
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview

List of Tables

Table 01: Global Hypopigmentation Disorders Treatment Market: Pipeline Analysis
Table 02: Global Hypopigmentation Disorders Treatment Market: Pipeline Analysis
Table 03: Global Hypopigmentation Disorders Treatment Market: Pipeline Analysis
Table 04: Global Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
Table 05: Global Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 06: Global Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 07: Global Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 08: North America Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 09: North America Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
Table 10: North America Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 11: North America Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 12: Europe Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 13: Europe Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
Table 14: Europe Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 15: Europe Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 16: Asia Pacific Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 17: Asia Pacific Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
Table 18: Asia Pacific Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 19: Asia Pacific Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 20: Latin America Hypopigmentation Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 21: Latin America Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
Table 22: Latin America Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 23: Latin America Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 24: Middle East & Africa Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 25: Middle East & Africa Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Treatment, 2016–2026
Table 26: Middle East & Africa Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 27: Middle East & Africa Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2026

List of Figures

Figure 01: Global Hypopigmentation Disorders Treatment Market Size (US$ Mn) and Distribution, by Region, 2017 and 2026
Figure 02: Global Hypopigmentation Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 03: Global Hypopigmentation Disorders Treatment Market Value Share, by Treatment, 2017
Figure 04: Global Hypopigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017
Figure 05: Global Hypopigmentation Disorders Treatment Market Value Share, by End-user, 2017
Figure 06: Global Hypopigmentation Disorders Treatment Market Value Share, by Region, 2017
Figure 07: Global Hypopigmentation Disorders Treatment Market Value Share, by Treatment, 2018 and 2026
Figure 08: Global Hypopigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Topical Drugs, 2016–2026
Figure 09: Global Hypopigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Laser Therapy, 2016–2026
Figure 10: Global Hypopigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chemical Peels, 2016–2026
Figure 11: Global Hypopigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Microdermabrasion, 2016–2026
Figure 12: Global Hypopigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 13: Global Hypopigmentation Disorders Treatment Market Attractiveness Analysis, by Treatment, 2018–2026
Figure 14: Global Hypopigmentation Disorders Treatment Market Value Share, by Disease Indication, 2018 and 2026
Figure 15: Global Hypopigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vitiligo, 2016–2026
Figure 16: Global Hypopigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Albinism, 2016–2026
Figure 17: Global Hypopigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 18: Global Hypopigmentation Disorders Treatment Market Attractiveness Analysis, by Disease Indication, 2018–2026
Figure 19: Global Hypopigmentation Disorders Treatment Market Value Share, by End-user, 2018 and 2026
Figure 20: Global Hypopigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2016–2026
Figure 21: Global Hypopigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Aesthetic Clinics & Dermatology Centers, 2016–2026
Figure 22: Global Hypopigmentation Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 23: Global Hypopigmentation Disorders Treatment Market Attractiveness Analysis, by End-user, 2018–2026
Figure 24: Global Hypopigmentation Disorders Treatment Market Value Share, by Region, 2018 and 2026
Figure 25: Global Hypopigmentation Disorders Treatment Market Attractiveness Analysis, by Region, 2018–2026
Figure 26: North America Hypopigmentation Disorders Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 27: North America Hypopigmentation Disorders Treatment Market Value Share, by Country, 2018 and 2026
Figure 28: North America Hypopigmentation Disorders Treatment Market Attractiveness, by Country, 2018–2026
Figure 29: North America Hypopigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
Figure 30: North America Hypopigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018–2026
Figure 31: North America Hypopigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
Figure 32: North America Hypopigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
Figure 33: North America Hypopigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
Figure 34: North America Hypopigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
Figure 35: Europe Hypopigmentation Disorders Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 36: Europe Hypopigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 37: Europe Hypopigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 38: Europe Hypopigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
Figure 39: Europe Hypopigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018–2026
Figure 40: Europe Hypopigmentation Disorders Treatment Market Value Share, by Disease Indication, 2018 and 2026
Figure 41: Europe Hypopigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
Figure 42: Europe Hypopigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
Figure 43: Europe Hypopigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
Figure 44: Asia Pacific Hypopigmentation Disorders Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 45: Asia Pacific Hypopigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 46: Asia Pacific Hypopigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 47: Asia Pacific Hypopigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
Figure 48: Asia Pacific Hypopigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018–2026
Figure 49: Asia Pacific Hypopigmentation Disorders Treatment Market Value Share, by Disease Indication, 2017 and 2026
Figure 50: Asia Pacific Hypopigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
Figure 51: Asia Pacific Hypopigmentation Disorders Treatment Market Value Share, by End-user, 2017 and 2026
Figure 52: Asia Pacific Hypopigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
Figure 53: Latin America Hypopigmentation Disorders Treatment Market value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 54: Latin America Hypopigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 55: Latin America Hypopigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 56: Latin America Hypopigmentation Disorders Treatment Market Value Share, by Treatment, 2017 and 2026
Figure 57: Latin America Hypopigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018–2026
Figure 58: Latin America Hypopigmentation Disorders Treatment Market Value Share, by Disease Indication, 2018 and 2026
Figure 59: Latin America Hypopigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
Figure 60: Latin America Hypopigmentation Disorders Treatment Market Value Share, by End-user, 2018 and 2026
Figure 61: Latin America Hypopigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
Figure 62: Middle East & Africa Hypopigmentation Disorders Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 63: Middle East & Africa Hypopigmentation Disorders Treatment Market Value Share, by Country/Sub-region, 2018 and 2026
Figure 64: Middle East & Africa Hypopigmentation Disorders Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 65: Middle East & Africa Hypopigmentation Disorders Treatment Market Value Share, by Treatment, 2018 and 2026
Figure 66: Middle East & Africa Hypopigmentation Disorders Treatment Market Attractiveness, by Treatment, 2018–2026
Figure 67: Middle East & Africa Hypopigmentation Disorders Treatment Market Value Share, by Disease Indication, 2018 and 2026
Figure 68: Middle East & Africa Hypopigmentation Disorders Treatment Market Attractiveness, by Disease Indication, 2018–2026
Figure 69: Middle East & Africa Hypopigmentation Disorders Treatment Market Value Share, by End-user, 2018 and 2026
Figure 70: Middle East & Africa Hypopigmentation Disorders Treatment Market Attractiveness, by End-user, 2018–2026
Figure 71: Allergan Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 72: Allergan R&D and Selling, General & Administrative Expenses (US$ Mn), 2016–2017
Figure 73: Allergan Breakdown of Net Sales (% Share), by Business Segment, 2017
Figure 74: Allergan Breakdown of Net Sales (% Share), by U.S. Specialized Therapeutics Segment, 2017
Figure 75: Pierre Fabre Breakdown of Employees (% Share), by Region, 2016
Figure 76: Pierre Fabre Breakdown of Net Sales (% Share), by Business Segment, 2017
Figure 77: Pierre Fabre Breakdown of Net Sales of Pharmaceuticals Division (% Share), by Region, 2016
Figure 78: Pierre Fabre Breakdown of Net Sales of Dermo-Cosmetics Division (% Share), by Region, 2016

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[色素脱失症治療の世界市場]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆